Statements (27)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:chemical_compound
|
| gptkbp:alternativeName |
gptkb:Amphetamine
|
| gptkbp:ATCCode |
gptkb:N06BA01
|
| gptkbp:boilingPoint |
203 °C
|
| gptkbp:CASNumber |
300-62-9
|
| gptkbp:chemicalFormula |
C10H15N
|
| gptkbp:hasUNII |
CK833KGX7E
|
| https://www.w3.org/2000/01/rdf-schema#label |
Amesen (3)
|
| gptkbp:IUPACName |
1-phenylpropan-2-amine
|
| gptkbp:legalStatus |
controlled substance in many countries
|
| gptkbp:meltingPoint |
11.3 °C
|
| gptkbp:molecularWeight |
135.21 g/mol
|
| gptkbp:PubChem_CID |
3007
2900 |
| gptkbp:relatedTo |
amphetamine
|
| gptkbp:routeOfAdministration |
oral
intravenous intranasal |
| gptkbp:sideEffect |
anxiety
loss of appetite increased heart rate insomnia |
| gptkbp:usedFor |
stimulant
treatment for narcolepsy medication for ADHD |
| gptkbp:bfsParent |
gptkb:Kandrian_Coastal_Rural_LLG
|
| gptkbp:bfsLayer |
8
|